Leads the global Oral Drug Product organization and delivery of oral drug product development from early phase through commercialization and lifecycle management.

Sets strategy and builds capabilities for robust, scalable oral formulations and manufacturing processes, including tech transfer and process validation/PPQ readiness.

Partners with PharmSci functions and key stakeholders (GSQ, Quality, Regulatory CMC, Commercial, R&D, Supply Chain) and external partners to deliver high-quality oral products.

Owns the global Oral Drug Product strategy and operating model to deliver phase-appropriate, scalable, and robust oral dosage forms across the pipeline and lifecycle.

Accountable for oral drug product design and development from pre-formulation through clinical and commercial readiness, including selection of dosage form, excipients, and process pathway consistent with target product profi...